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Abstract 
Mitochondrial dysfunction is central to the pathogenesis of neurological disorders. Neurons rely 
on oxidative phosphorylation to meet their energy requirements and thus alterations in 
mitochondrial function are linked to energy failure and neuronal cell death. Furthermore, 
dysfunctional mitochondria are reported to increase the steady-state levels of reactive oxygen 
species derived from the leakage of electrons from the electron transport chain. Research 
aimed at understanding mitochondrial dysfunction and its role in neurological disorders has 
been primarily geared towards neurons. In contrast, the role that dysfunctional mitochondria 
have in glial cells’ function and its implication for neuronal homeostasis and brain function has 
been largely understudied. Except for oligodendrocytes, astrocytes and microglia do not 
degenerate upon the impairment of mitochondrial function, as they rely primarily on glycolysis to 
produce energy and have a higher antioxidant capacity than neurons. However, recent evidence 
highlights the role of mitochondrial metabolism and signaling in glial cell function. In this work, 
we review the functional role of mitochondria in glial cells and the evidence regarding its 
potential role regulating neuronal homeostasis and disease progression.  
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1. Introduction 
Mitochondria are involved in a myriad of other processes relevant for cell function besides 
energy (ATP) production (Yin et al. 2014), making them more than simply powerhouses of the 
cell. Mitochondria are a hub for signaling processes that include the maintenance of calcium 
(Ca2+) homeostasis and the formation of signaling molecules and thus, signaling events (Bonini ; 
Chandel 2015).  For example, cell death progression is well known to be triggered by the 
release of mitochondrial pro-death proteins.  Alterations in mitochondrial functions are expected 
to have important implications for cellular function and disease progression. Correspondingly, 
numerous pathological conditions have been connected to mitochondrial dysfunction. 
Neuronal cell death in brain disorders (neurodegeneration) and injury (neurotoxicity and 
ischemia) has been linked to a variety of alterations in mitochondrial homeostasis/function 
including traffic, quality control and turnover, homeostasis (bioenergetics and electron transport)  
and signaling (metabolism and Ca2+ handling) (Chaturvedi and Flint Beal 2013; Yin et al. 2014). 
Compared to other cell types, neurons are more dependent on mitochondrial oxidative 
phosphorylation (OXPHOS) to fulfill their energy demands. Mitochondrial dysfunction with the 
concomitant energy failure and increased generation of reactive oxygen species (ROS) are 
considered central to neuronal cell loss in brain disorders because neurons have a limited 
capacity to upregulate glycolysis or to counteract oxidative damage (Fernandez-Fernandez et 
al. 2012; Herrero-Mendez et al. 2009). As such, research has been primarily directed at 
understanding the causes and consequences of mitochondrial dysfunction in neuronal 
populations affected during neurodegeneration or brain injury (Moran et al. 2012; Yin et al. 
2014). 
While initially considered as accessory cells to neurons, glial cells are now recognized to be 
essential for neuronal cell homeostasis, survival and proper brain function and development 
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(Bolanos 2016; Fernandez-Fernandez et al. 2012; Kubik and Philbert 2015). Importantly, 
genetic modifications or xenobiotics (i.e. pesticides [rotenone or paraquat], metals [lead, 
arsenic], antibiotics and drugs that target the integrity of mitochondrial DNA) recognized to alter 
mitochondrial function in neurons are expected to alter mitochondrial function in glial cells as 
well (Ballinger ; Chan ; Kubik and Philbert 2015; Meyer et al. 2013). Unfortunately, very few 
studies have addressed the pathological implications of mitochondrial dysfunction in glial cells 
and its consequences in neurological disorders. Herein, we review the current evidence 
demonstrating the importance of mitochondrial homeostasis and signaling in glial function and 
how their functional deficiency has important implications for brain disorders and injury that lead 
to or are a consequence of neuronal cell death. 
2. Glial cell types and their functional roles 
Glial cells can be generally classified as macroglia (astrocytes and oligodendrocytes) or 
microglia. Macroglia originate from the embryonic ectoderm, while microglia originate from the 
mesoderm and enter the vertebrate brain during embryogenesis. While initially grouped under 
the term “glia” (Greek term for glue), it is now clearly established that glial cells regulate a 
number of physiological processes required for proper neuronal survival and brain function. 
Refinement and revision of counting techniques have demonstrated that while the overall ratio 
of neurons to glial varies between different regions in the brain, a ratio of ~1:1 glia to neuron 
exists in the entire human brain, which is significantly smaller than previous estimates (~10:1). 
Oligodendrocytes are reported to be the most abundant type of glial cells (45–75%), followed by 
astrocytes (19–40%), and microglia (10% or less) (von Bartheld et al. 2016). 
Oligodendrocytes are responsible for axon myelination at large membrane extensions, providing 
axons with an “insulating coat” that enhances nerve impulse conduction (Figure 1.4). 
Oligodendrocytes have several extensions that form several internodal segments of myelin 
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separated by gaps (Ranvier nodes) (Baumann and Pham-Dinh 2001; Snell 2010). 
Oligodendrocytes are found in both gray and white matter, but are a major fraction of all the 
cells in white matter.  
Astrocytes are small cells with processes that are radially arranged, and have considerable 
molecular, structural, and functional diversity at the regional level. Astrocyte extensions cover 
the external surface of brain capillaries (perivascular feet), the synaptic cleft between the pre-
synaptic and the post-synaptic terminals, and the bare segments of axons at the Ranvier nodes 
(Figure 1.2). Astrocytes also form highly organized domains interconnected via gap junctions 
with other astrocytes and oligodendrocytes (Figure 1.2). Additionally, astrocytes regulate 
neurotransmitter levels in the synaptic cleft, provide neurons with energetic and antioxidant 
precursors (Figure 1.2), play an important role in neuro/synaptogenesis and tissue repair, and 
also regulate blood flow and inflammatory processes by the release of signaling mediators 
(Sofroniew and Vinters 2010).  
Microglial cells are resident macrophages distributed throughout the central nervous system 
(CNS) (Byrne and Roberts 2009). As innate immune cells, microglia are activated by infection, 
tissue injury, or xenobiotics. Upon activation, microglia cells retract their cytoplasmic extensions 
and migrate to the site of injury, where they proliferate and become antigen presenting cells. 
Microglia phagocytose degenerating cells and act as sources of immunoregulatory and 
neuromodulatory factors such as cytokines, chemokines and neurotrophic factors. Microglia can 
be activated by cell-surface receptors for endotoxins, cytokines, chemokines, misfolded 
proteins, serum factors and ATP (Figure 1.5). While mild activation is a key adaptive immune 
response, continuous activation or overactivation of microglia is thought to contribute to 
neurodegeneration (Finsen and Owens 2011; Hanisch 2013; Hanisch and Kettenmann 2007).  
3. Mitochondrial dysfunction in glial cells and its effect on neuronal function/survival 
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3.1. Cell death 
Apoptosis is a ubiquitous homeostatic mechanism critical for the turnover of cells throughout the 
lifespan of multi-cellular organisms.  However, dysregulation of apoptosis occurs as either a 
cause or consequence of distinct pathologies that include neurodegenerative disorders (Fadeel 
and Orrenius 2005). The signaling pathways that regulate the progression of apoptosis have 
been extensively characterized and divided in two pathways. Induction of apoptosis via the 
extrinsic pathway is triggered by the activation of the death receptors leading to the activation of 
initiator caspases. (Lavrik et al. 2005). 
The intrinsic mitochondrial pathway of apoptosis is activated by a wide variety of stimuli that 
regulate the expression and function of the Bcl-2 (B-cell lymphoma 2) family of (anti or pro) 
apoptotic proteins. The BH3-only Bcl-2 family members (Bad, Bid, Bim and NOXA) regulate the 
anti-apoptotic Bcl-2 proteins (Bcl-2, Bcl-xl and Mcl-1) to promote apoptosis. The pro-apoptotic 
effector proteins Bax and Bak are sufficient and necessary for inducing the permeabilization of 
the outer mitochondrial membrane and the release of Cyt C (Figure 2.6). However, the 
activation of BH3-only proteins derepresses the direct inhibition of Bax and Bak by anti-
apoptotic Bcl-2 proteins. Released Cyt C leads to the recruitment of Apaf1 and caspase 9 into a 
platform (apoptosome) that activates caspase 9 and subsequently, executioner caspases 3, 6 
and 7. The extrinsic / death receptor pathway can crosstalk to the intrinsic / mitochondrial 
pathway of apoptosis by an amplification loop induced by caspase dependent 
cleavage/activation of Bid (Green and Llambi 2015). 
While a number of studies have reported the induction of apoptosis in astrocytes and microglia 
under different experimental conditions, very little evidence exists about the loss or 
degeneration of these glial cells with respect to human disorders. Conversely, oligodendrocytes 
are known to degenerate in demyelinating disorders such as multiple sclerosis, and to be 
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affected directly or indirectly by the majority of known disorders in the CNS including ischemia, 
trauma and neurodegeneration. Glutamate/Ca2+ excitotoxicity, inflammation (cytokines) and 
oxidative stress are common triggers for oligodendrocyte injury in these pathological situations 
(Figure 1.4). Oligodendrocytes express ionotropic α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA)/kainite receptors whose activation induces Ca2+ overflow and 
apoptotic cell death via the intrinsic mitochondrial pathway via activation of Bax and caspase 3 
(Figure 1.4) (Ruiz et al. 2010; Sanchez-Gomez et al. 2011). The high lipid and iron content of 
oligodendrocytes also makes them susceptible to oxidative damage induced by cytokines 
(Zhang et al. 2005). 
3.2. Bioenergetics and metabolism 
Neurons are dependent on high rates of OXPHOS to meet their energy requirements, to 
maintain and restore ionic gradients, and for the uptake and recycling of neurotransmitters.  In 
contrast, astrocytes are highly glycolytic (Figure 2.1), but a large portion of glucose is converted 
to lactate and released to the extracellular space. Interestingly, glucose consumption in 
astrocytes exceeds their energy expenditure, which is explained by the astrocytes-neuron 
lactate shuttle hypothesis where lactate is shuttled from astrocytes (and oligodendrocytes) as a 
fuel for OXPHOS in neurons (Figure 1.1 and 2.2) (Belanger et al. 2011; Funfschilling et al. 
2012a; Lee et al. 2012; Morrison et al. 2013).  What limits OXPHOS in astrocytes? Recent 
studies have demonstrated that the activity of pyruvate dehydrogenase (PDH), which provides a 
route of entry for pyruvate into the tricarboxylic acid (TCA or Krebs) cycle, is reduced by its 
phosphorylation in astrocytes (Figure 1.1 and 2.3) (Halim et al. 2010). Interestingly, astrocytes 
have the same oxidative capacity as neurons, but are resilient to mitochondrial dysfunction (Di 
Monte et al. 1992).   
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Other carbon sources can fuel OXPHOS in astrocytes. Glutamate can be metabolized through 
the TCA cycle, but astrocytes primarily metabolize it to glutamine by the activity of glutamine 
synthase (GS) (Figure 2.4). However, when the extracellular concentration of glutamate 
increases to levels observed during synaptic transmission, the proportion of glutamate 
metabolized by the TCA cycle increases as well, while its conversion to glutamine decreases 
concomitantly (McKenna 2013; Nissen et al. 2015; Schousboe et al. 2014). Importantly, 
glutamate also exerts a stimulatory effect on glycolysis as well (Loaiza et al. 2003; Pellerin and 
Magistretti 1994). 
Acetate is also used as a carbon source by astrocytes, but its physiological significance has not 
been established (Belanger et al. 2011; Jiang et al. 2013). Astrocytes can oxidize free fatty 
acids (FFA) and ketone bodies, but neurons and oligodendrocytes can only use ketone bodies 
as these cell types would be highly vulnerable to ROS formation generated by FFA oxidation 
due to their high lipid content (Iglesias et al. 2016; Schonfeld and Reiser 2013). Twenty percent 
of total energy expenditure in the brain is linked to FFA oxidation (FAO), which occurs primarily 
in astrocytes (Ebert et al. 2003). As mentioned above, astrocytes exhibit high rates of OXPHOS 
(Lovatt et al. 2007), but a larger proportion of astrocyte PDH is phosphorylated compared to 
neuronal PDH, inhibiting the conversion of pyruvate to acetyl-CoA (Halim et al. 2010). Thus, 
FAO might actually be a major source for acetyl-CoA into the TCA cycle (Panov et al. 2014) 
(Figure 2.3). 
Oligodendrocytes have similar rates of glycolysis compared to astrocytes, but release less 
lactate since a larger proportion of pyruvate derived from glucose is metabolized via PDH into 
the TCA cycle. Similar to astrocytes, oligodendrocytes can carboxylate pyruvate to oxaloacetate 
via pyruvate carboxylase (PC) to replenish TCA intermediates (anaplerosis) or recycle pyruvate 
(Figure 2.3) (Amaral et al. 2016). In astrocytes however, pyruvate carboxylation also serves to 
compensate for the loss of TCA intermediates due to the generation of glutamate and 
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subsequently glutamine that is then shuttled to neurons (glutamate-glutamine cycle) (Figure 1.2 
and 2.4) (Schousboe et al. 2014). Lactate metabolism in oligodendrocytes has been 
demonstrated to participate in oligodendrocyte differentiation and myelination.(Rinholm et al. 
2011). Importantly, mitochondrial respiration / metabolism seems to be primarily involved in 
oligodendrocyte differentiation, while glycolysis appears to be sufficient to maintain post-
myelinated (differentiated) oligodendrocytes (Funfschilling et al. 2012b). Accordingly, 
demyelination disorders linked to mitochondrial dysfunction seem to be primarily linked to 
increased oxidative damage and changes in FFA metabolism but not energy failure (Lin et al. 
2012; Swalwell et al. 2011; Viader et al. 2013). 
3.3. Calcium 
Calcium (Ca2+) signaling is tightly coupled to its homeostasis. Ca2+ gradients across membranes 
and cellular compartments are established by the activity of Ca2+ pumps / transporters. The 
controlled activation of Ca2+ fluxes allows its release and the subsequent activation of a diverse 
array of signal transducers including kinases, enzymes and ion channels. Mitochondria are now 
recognized as important Ca2+ reservoirs or sinks. The regulation of Ca2+ signaling is not a 
simple process of its release and subsequent compartmentalization. Instead, it involves a highly 
localized release and controlled diffusion of Ca2+ across intracellular compartments and in most 
cases, the coordinated action of more than one Ca2+ reservoir and release / uptake system. The 
spatiotemporal complexity of this process is reflected by the existence of patterns of Ca2+ waves 
or sparks that are decoded by transducers selectively localized in different cellular 
compartments. Sequestration of Ca2+ within the mitochondrial matrix is partially driven by the 
negative environment generated by the extrusion of protons (H+) across the inner mitochondrial 
membrane by the ETC (Figure 2.3). Translocation of Ca2+ into the matrix is mediated by the 
mitochondrial Ca2+ uniporter (MCU) in an energy-independent manner (Figure 2.5). Ca2+ 
release from the mitochondria is mediated by Ca2+ exchangers (the sodium [Na+)]/Ca2+ [mNCX] 
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and mitochondrial proton [H+]/Ca2+ exchangers [mHCX]), or the opening of the mitochondrial 
permeability transition pore under pathological conditions (Figure 2.5). Importantly, 
mitochondria act as important buffers for Ca2+ release / influx from the endoplasmic reticulum 
(ER) and the plasma membrane that contribute to the regulation of Ca2+ signaling (Figure 2.5) 
(Rizzuto et al. 2012). 
Very little is known about the impact of mitochondrial Ca2+ homeostasis on glial signaling. 
However, as in other cell types, functional mitochondria in astrocytes and oligodendrocytes 
regulates Ca2+ waves generated by the activation of inositol 1,4,5-triphosphate (IP3) receptors 
(IP3R) and the release of Ca2+ from the ER (Boitier et al. 1999; Simpson and Russell 1996; 
Smith et al. 2005). Mitochondrial Ca2+ has also been shown to regulate vesicular glutamate 
release from astrocytes that modulates synaptic communication and excitability (Reyes and 
Parpura 2008). Ca2+ accumulation in mitochondria also modulates oxidative phosphorylation 
and energy production. PDH activity is regulated by a Ca2+-dependent dephosphorylation, while 
Ca2+ binding also regulates α-ketoglutarate (DKGDH)- and isocitrate (IDH)-dehydrogenase 
activity, which  increases NADH levels, electron flow and ATP synthesis (Figure 2.5) (Rizzuto et 
al. 2012). Accordingly, Ca2+ release from the ER stimulates mitochondrial-dependent energy 
production in astrocytes (Wu et al. 2007). Not only do mitochondria regulate Ca2+ accumulation 
and dynamics, but also its release. A recent report demonstrated that Ca2+ release via mNCX is 
coupled to store-operated Ca2+ entry (triggered by Ca2+ depletion from ER stores) and regulates 
astrocytes proliferation and excitotoxic glutamate release (Parnis et al. 2013). In microglia, 
mitochondrial Ca2+ influx via the mitochondrial transient receptor potential vanilloid 1 channel 
(TRPV1) depolarizes mitochondria resulting in mtROS production, mitogen activated protein 
kinase (MAPK) activation, and enhanced migration (Miyake et al. 2015). 
3.4. Inflammation 
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Inflammation is a key contributor to most neurological disorders. In a steady “basal” state, 
microglia performs continuous surveillance of the CNS, secrete neurotrophic factors, such as 
insulin-like growth factor 1 (IGF1), brain-derived neurotrophic factor (BDNF), transforming 
growth factor-β (TGFβ) and nerve growth factor (NGF), and promote synapse pruning for 
refinement of neuronal circuits during development.  Classical activation of microglia (M1) 
conveys the production of ROS and nitrogen species (RNS) and the release of pro-inflammatory 
cytokines (tumor necrosis factor [TNF] and interleukin-1β [IL-1β]) to promote brain tissue repair 
upon injury (removal of cell debris and restoring of tissue integrity) and, upon prolonged 
activation, neuronal dysfunction as well. Disease-associated factors such as xenobiotics, protein 
aggregates, and damage (DAMPs) or pathogen-associated molecular patterns (PAMPS) can 
activate microglia through a variety of surface receptors. These receptors include Toll-like 
receptors (for lipopolysacharide [LPS], oxidized low-density lipoprotein [LDL] and molecules 
released by damaged or dead cells including high-mobility group box 1 [HMGB1] and 
nucleotides), nucleotide-binding oligomerization domain (Nod)-like receptors (for amyloid 
proteins), advanced glycation end-products receptors or RAGE (that are also activated by 
HMGB1), and purinergic receptors (for purines and pyrimidines including nucleoside 
triphosphates, e.g. ATP) (Hu et al. 2014). Pro-inflammatory cytokines released from microglia 
also “activate” astrocytes, which might produce TNF to potentiate microglia activation as well. 
As such, co-cultures of microglia and astrocytes produce more neurotoxic factors than either 
activated cell type alone (Saijo and Glass 2011). Whether astrocytes can be activated in the 
absence of microglia is still unclear since most studies using primary cultures of astrocytes also 
contain at least 5% of microglia that significantly contribute to astrocyte activation (Facci et al. 
2014; Marinelli et al. 2015). The alternative (M2-like) phenotype of microglia is observed to be 
induced by transforming growth factor-β (TGFβ), IL-4, IL-6 and IL-10 secreted from glioma cells 
(Saijo and Glass 2011). 
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Mitochondrial dysfunction triggers inflammatory responses (West). During inflammation, 
changes in mitochondrial metabolism contribute to the activation of microglia. The M1 
phenotype of microglia was recently reported to be paralleled by a metabolic switch from 
mitochondrial OXPHOS to glycolysis that enhances carbon flux to the PPP (Figure 1.5) 
(Gimeno-Bayon et al. 2014; Orihuela et al. 2016; Voloboueva et al. 2013). Interestingly, 
inhibition of complex I activity activates microglial cells (Shaikh and Nicholson 2009; Ye et al. 
2016; Yuan et al. 2013), while impairment of mitochondrial fission reduces the production of pro-
inflammatory signals (Park et al. 2013). Induction of the M2-like phenotype results in no 
observable changes in mitochondrial oxygen consumption or lactate production (Orihuela et al. 
2016). However, mitochondrial toxins such as 3-nitropropionic acid and rotenone impair the 
transition to the M2 phenotype induced by IL-4 (Ferger et al. 2010). These results suggest that 
mitochondrial dysfunction in microglia can exacerbate the pro-inflammatory M1 phenotype and 
result in the release of neurotoxic pro-inflammatory cytokines, and enhanced ROS / RNS 
formation (Tang and Le 2016).  
3.5. Redox homeostasis and detoxification of xenobiotics 
In general, neurons have limited defense mechanisms against ROS compared to astrocytes. 
This enhanced resistance to oxidative damage in astrocytes is observed despite the fact that 
astrocytes have a deficient mitochondrial respiration and increased ROS formation when 
compared to neurons (Lopez-Fabuel et al. 2016). A comparative study also demonstrated that 
astrocytes are more resistant to oxidative damage than microglia or oligodendrocytes 
(Hollensworth et al. 2000). Astrocytes contain higher levels of endogenous antioxidants and 
antioxidant systems that include NADPH and G6PD (glucose-6-phosphate dehydrogenase). 
Astrocytes’ resistance to oxidative damage is explained by the activation of the antioxidant 
response via the nuclear factor erythroid-2-related factor 2 (Nrf2) transcription factor (Garcia-
Nogales et al. 2003; Shih et al. 2003). Both neurons and astrocytes can synthesize GSH, but 
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neurons depend on the supply of GSH precursors from astrocytes (Figure 1.3). GSH is 
released from astrocytes via the ATP-binding cassette transporters subfamily C member 1 
transporter (ABCC1, or multidrug-resistance-associated protein 1 [MRP1]) (Hirrlinger and 
Dringen 2005). Extracellular GSH is then degraded by the γ-glutamyl transpeptidase (γGT) to 
produce l-cysteine-l-glycine (CysGly), which is cleaved further by the neuronal aminopeptidase 
N (ApN) into the amino acids glycine and cysteine that are taken up by neurons for de novo 
GSH synthesis (Figure 1.3) (Aoyama et al. 2008; Belanger et al. 2011). The glutamate-
glutamine cycle might also be involved in the regulation of the neuronal redox environment by 
astrocytes since GSH synthesis also requires glutamate. The importance of astrocytes for 
neuronal redox homeostasis was evidenced by a recent study demonstrating that conditional 
depletion of astrocytes promotes neuronal injury by oxidative stress (Schreiner et al. 2015). 
Astrocytes are also the first line of defense against xenobiotics entering into the brain since their 
extensions cover the external surface of capillaries as part of the blood brain barrier. 
Detoxification of electrophiles is dependent the formation of irreversible adducts with GSH that 
in many cases depends on the activity of glutathione-S-transferases (GST) and their efflux 
through MRPs (Dringen et al. 2015). 
But what is the role of mitochondria in redox homeostasis in astrocytes and neurons? The loss 
of GSH by its export to neurons or due to the detoxification of electrophiles is expected to 
prompt astrocytes to replenish GSH precursors. Interestingly, GSH depletion upregulates 
mitochondrial activity in astrocytes (Vasquez et al. 2001) and we have recently observed that 
mitochondrial OXPHOS is essential for the detoxification of electrophiles via the GSH/MRP 
system (manuscript in preparation), but the exact mechanisms that regulate this phenomenon 
are still unclear. 
4. Conclusions and Perspectives 
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Mitochondrial dysfunction has been widely recognized as central to the pathogenesis of 
neurological disorders. However, the majority of current research efforts have been focused on 
understanding the causes and consequences of mitochondrial dysfunction in neuronal cells that 
rely on OXPHOS to generate energy and are also more sensitive to mitochondrial ROS 
formation. Less is known about the functional role of mitochondria in glial cells and its 
implications for neuronal survival and brain function. In this work, we have provided an overview 
of the role of mitochondria in glial cell function that includes metabolism, redox homeostasis, 
Ca2+ signaling, inflammation and cell death. The evidence so far clearly demonstrates the 
importance of mitochondrial health in glial cells and its relevance to neuronal function. 
Nevertheless, this review also highlights our limited understanding of mitochondria function in 
glial cells and the need for further investigations in this area that is expanding. For example, 
recent studies have demonstrated that damaged mitochondria can be transferred from neuronal 
axons for their turnover in astrocytes (Davis et al. 2014), and conversely, astrocytes have been 
shown to transfer mitochondria to promote neuronal survival (Hayakawa et al. 2016) (Figure 
1.3). Many questions remain to be answered regarding the role of mitochondrial in neurological 
disorders, but it is time for us to think about mitochondrial health and dysfunction in a more 
inclusive context outside neuronal cells. 
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Figure Legends 
Figure 1. Neuronal metabolism, redox homeostasis and signaling are supported by neighboring 
glial cells. 1.1: Glucose and lactate enter the brain through Glut1 (glucose transporter 1) and 
MCT1 (monocarboxylate transporter 1) transporters in the vascular epithelium. Glucose (Glut3) 
and lactate (MCT1 or 2) are uptaken from the extracellular space by neuronal calls to fuel the 
TCA cycle for the generation of ATP and biosynthesis of essential molecules. 1.2: As a 
component of the blood brain barrier (BBB), astrocytes uptake glucose from the capillary 
epithelium via Glut1 as well, converting the majority of pyruvate (Pyr) generated into lactate 
which is exported by MCT1. Astrocytes also uptake the neurotransmitter glutamate (Glu) from 
the synaptic cleft via EAAT (excitatory amino acid transporters) to be (a) converted into 
glutamine (Gln), (b) exchanged for extracellular cystine (Cys) by xCT, (c) feed into the TCA 
cycle, or (d) for GSH synthesis. Astrocytes form extended networks with other glia 
(oligodendrocytes and astrocytes) via gap junctions, sharing nutrients and molecular 
components with cells more distal to the capillaries. 1.3: Astrocytes contribute to the redox state 
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of neuronal cells by exporting GSH via MRP1 which is broken down by γGT and ApN into its 
amino acid components to be uptaken and reassembled as GSH in neuronal cells. 
Dysfunctional or damaged mitochondrial, likely capable of generating ROS, are transferred from 
neurons to astrocytes to be degraded by mitophagy. 1.4: Oligodendrocytes wrap neuronal 
projections (myelin sheaths) improving signal conduction and like astrocytes, have been 
proposed to shuttle lactate to the neurons. 1.5: Microglia are activated by a variety of factors, 
including cytokines, oxidized proteins, and protein aggregates. Activated microglia migrate to 
the site of damage and can induce neuronal or oligodendrocyte cell death through the release of 
cytokines, and the generation of ROS via NADPH oxidases (NOX) and nitric oxide synthases 
(NOS). AA-T, amino acid transporters; LDH1 or 5, lactate dehydrogenase isoform 1 or 5. 
Figure 2. Mitochondrial metabolism and signaling in astrocytes. 2.1: Glucose in astrocytes is 
used for glycogenesis, NADPH production through the PPP, or glycolysis. Astrocytes are highly 
glycolytic due to the expression of high levels of 6‐phosphofructo‐2‐kinase / 
fructose‐2,6‐bisphosphatase‐3 (PFKFB3), whose byproduct fructose‐2,6‐bisphosphate 
(F2,6P2), is a positive effector  of the glycolytic enzyme 6‐phosphofructo‐1‐kinase (PFK1). In 
addition, the activity of PFKFB3 is increased by phosphorylation by 5′‐AMP‐activated protein 
kinase (AMPK) (Bolanos 2016). 2.2: Astrocytes primarily derive ATP from glycolysis rather than 
oxidative phosphorylation, where pyruvate is converted to lactate by LDH5 and exported to the 
extracellular space to be consumed by neurons. 2.3: Astrocytes carboxylate pyruvate to 
oxaloacetate (OAA) via pyruvate carboxylase (PC) to regenerate TCA cycle intermediates. 
Phosphorylation of pyruvate dehydrogenase (PDH) restricts the conversion of pyruvate to 
acetyl-CoA (Ac-CoA). Thus, FAO has been proposed to be the primary contributor of Ac-CoA to 
the TCA cycle. 2.4: Alpha ketoglutarate (αKG) generated from the TCA cycle can be transported 
to the cytosol and converted to Glu by glutamic-oxaloacetic transaminase 1 or aspartate (Asp) 
aminotransferase (GOT1) as part of the malate-Asp shuttle. Glu has three central metabolic 
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pathways in astrocytes. 1) Glu can be converted to Gln by GS and exported to neurons by the 
sodium-coupled neutral amino acid transporter 3 (SNAT3). 2) Glu is exchanged via xCT for 
extracellular cystine that is reduced to Cys. Extracellular Glu can be uptaken back by astrocytes 
by EAAT1/2. Finally, 3) Glu, Gly and Cys are precursors of GSH, which is also exported to 
neurons via MRP1. 2.5: The ER acts as a store for intracellular calcium, where the 
sarco/endoplasmic reticulum calcium ion ATPase (SERCA) pumps cytosolic Ca2+ into the ER. 
Ca2+ signaling is tightly regulated by the activation of IP3R that release Ca2+ from ER stores, as 
well as by the activation of plasma membrane Ca2+ channels. Mitochondria can buffer Ca2+ by 
its transport across the inner mitochondrial membrane to the matrix viaMCU), while the export is 
performed by mNCX and mHCX. Mitochondria can also transport Ca2+ in and out of the 
mitochondria via the activation of distinct Ca2+ permeable channels. In the matrix, Ca2+ 
stimulates TCA carbon flux by binding to PDH, IDH, and αKGDH, increasing the activity of the 
ETC and ATP production. 2.6: Cyt C is held close to the inner mitochondrial membrane by 
cardiolipin (not shown), acting as a component of ETC. Dissociation of Cyt C from cardiolipin, 
through oxidative or enzymatic means, coupled with permeabilization of the outer mitochondrial 
membrane by the formation of Bax/Bak oligomeric channels, allows Cyt C to escape into the 
cytosol. Cytosolic Cyt C associates with apoptotic protease-activating factor 1 (APAF1), forming 
the apoptosome and leading to the activation of caspases to initiate apoptosis. AGC, aspartate-
glutamate carrier; CPT1 or 2, carnitine palmitoyltransferase isoform 1 or 2; MDH1 or 2, malate 
dehydrogenase isoform 1 or 2; MPC1, mitochondrial pyruvate carrier 1; OGC, 2-oxoglutarate (α-
ketoglutarate) carrier. 
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Abstract 
Mitochondrial dysfunction is central to the pathogenesis of neurological disorders. Neurons rely 
on oxidative phosphorylation to meet their energy requirements and thus alterations in 
mitochondrial function are linked to energy failure and neuronal cell death. Furthermore, 
dysfunctional mitochondria are reported to increase the steady-state levels of reactive oxygen 
species derived from the leakage of electrons from the electron transport chain. Research 
aimed at understanding mitochondrial dysfunction and its role in neurological disorders has 
been primarily geared towards neurons. In contrast, the role that dysfunctional mitochondria 
have in glial cells’ function and its implication for neuronal homeostasis and brain function has 
been largely understudied. Except for oligodendrocytes, astrocytes and microglia do not 
degenerate upon the impairment of mitochondrial function, as they rely primarily on glycolysis to 
produce energy and have a higher antioxidant capacity than neurons. However, recent evidence 
highlights the role of mitochondrial metabolism and signaling in glial cell function. In this work, 
we review the functional role of mitochondria in glial cells and the evidence regarding its 
potential role regulating neuronal homeostasis and disease progression.  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
3 
 
Contents:  
1. Introduction 
2. Glial cell types and their functional roles 
3. Mitochondrial dysfunction in glial cells and its effect on neuronal function/survival 
3.1. Cell death 
3.2. Bioenergetics and metabolism 
3.3. Calcium 
3.4. Inflammation 
3.5. Redox homeostasis and detoxification of xenobiotics 
4. Conclusions and perspectives 
 
 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
4 
 
1. Introduction 
Mitochondria are involved in a myriad of other processes relevant for cell function besides 
energy (ATP) production (Yin et al. 2014), making them more than simply powerhouses of the 
cell. Mitochondria are a hub for signaling processes that include the maintenance of calcium 
(Ca2+) homeostasis and the formation of signaling molecules and thus, signaling events (Bonini ; 
Chandel 2015).  For example, cell death progression is well known to be triggered by the 
release of mitochondrial pro-death proteins.  Alterations in mitochondrial functions are expected 
to have important implications for cellular function and disease progression. Correspondingly, 
numerous pathological conditions have been connected to mitochondrial dysfunction. 
Neuronal cell death in brain disorders (neurodegeneration) and injury (neurotoxicity and 
ischemia) has been linked to a variety of alterations in mitochondrial homeostasis/function 
including traffic, quality control and turnover, homeostasis (bioenergetics and electron transport)  
and signaling (metabolism and Ca2+ handling) (Chaturvedi and Flint Beal 2013; Yin et al. 2014). 
Compared to other cell types, neurons are more dependent on mitochondrial oxidative 
phosphorylation (OXPHOS) to fulfill their energy demands. Mitochondrial dysfunction with the 
concomitant energy failure and increased generation of reactive oxygen species (ROS) are 
considered central to neuronal cell loss in brain disorders because neurons have a limited 
capacity to upregulate glycolysis or to counteract oxidative damage (Fernandez-Fernandez et 
al. 2012; Herrero-Mendez et al. 2009). As such, research has been primarily directed at 
understanding the causes and consequences of mitochondrial dysfunction in neuronal 
populations affected during neurodegeneration or brain injury (Moran et al. 2012; Yin et al. 
2014). 
While initially considered as accessory cells to neurons, glial cells are now recognized to be 
essential for neuronal cell homeostasis, survival and proper brain function and development 
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(Bolanos 2016; Fernandez-Fernandez et al. 2012; Kubik and Philbert 2015). Importantly, 
genetic modifications or xenobiotics (i.e. pesticides [rotenone or paraquat], metals [lead, 
arsenic], antibiotics and drugs that target the integrity of mitochondrial DNA) recognized to alter 
mitochondrial function in neurons are expected to alter mitochondrial function in glial cells as 
well (Ballinger ; Chan ; Kubik and Philbert 2015; Meyer et al. 2013). Unfortunately, very few 
studies have addressed the pathological implications of mitochondrial dysfunction in glial cells 
and its consequences in neurological disorders. Herein, we review the current evidence 
demonstrating the importance of mitochondrial homeostasis and signaling in glial function and 
how their functional deficiency has important implications for brain disorders and injury that lead 
to or are a consequence of neuronal cell death. 
2. Glial cell types and their functional roles 
Glial cells can be generally classified as macroglia (astrocytes and oligodendrocytes) or 
microglia. Macroglia originate from the embryonic ectoderm, while microglia originate from the 
mesoderm and enter the vertebrate brain during embryogenesis. While initially grouped under 
the term “glia” (Greek term for glue), it is now clearly established that glial cells regulate a 
number of physiological processes required for proper neuronal survival and brain function. 
Refinement and revision of counting techniques have demonstrated that while the overall ratio 
of neurons to glial varies between different regions in the brain, a ratio of ~1:1 glia to neuron 
exists in the entire human brain, which is significantly smaller than previous estimates (~10:1). 
Oligodendrocytes are reported to be the most abundant type of glial cells (45–75%), followed by 
astrocytes (19–40%), and microglia (10% or less) (von Bartheld et al. 2016). 
Oligodendrocytes are responsible for axon myelination at large membrane extensions, providing 
axons with an “insulating coat” that enhances nerve impulse conduction (Figure 1.4). 
Oligodendrocytes have several extensions that form several internodal segments of myelin 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
6 
 
separated by gaps (Ranvier nodes) (Baumann and Pham-Dinh 2001; Snell 2010). 
Oligodendrocytes are found in both gray and white matter, but are a major fraction of all the 
cells in white matter.  
Astrocytes are small cells with processes that are radially arranged, and have considerable 
molecular, structural, and functional diversity at the regional level. Astrocyte extensions cover 
the external surface of brain capillaries (perivascular feet), the synaptic cleft between the pre-
synaptic and the post-synaptic terminals, and the bare segments of axons at the Ranvier nodes 
(Figure 1.2). Astrocytes also form highly organized domains interconnected via gap junctions 
with other astrocytes and oligodendrocytes (Figure 1.2). Additionally, astrocytes regulate 
neurotransmitter levels in the synaptic cleft, provide neurons with energetic and antioxidant 
precursors (Figure 1.2), play an important role in neuro/synaptogenesis and tissue repair, and 
also regulate blood flow and inflammatory processes by the release of signaling mediators 
(Sofroniew and Vinters 2010).  
Microglial cells are resident macrophages distributed throughout the central nervous system 
(CNS) (Byrne and Roberts 2009). As innate immune cells, microglia are activated by infection, 
tissue injury, or xenobiotics. Upon activation, microglia cells retract their cytoplasmic extensions 
and migrate to the site of injury, where they proliferate and become antigen presenting cells. 
Microglia phagocytose degenerating cells and act as sources of immunoregulatory and 
neuromodulatory factors such as cytokines, chemokines and neurotrophic factors. Microglia can 
be activated by cell-surface receptors for endotoxins, cytokines, chemokines, misfolded 
proteins, serum factors and ATP (Figure 1.5). While mild activation is a key adaptive immune 
response, continuous activation or overactivation of microglia is thought to contribute to 
neurodegeneration (Finsen and Owens 2011; Hanisch 2013; Hanisch and Kettenmann 2007).  
3. Mitochondrial dysfunction in glial cells and its effect on neuronal function/survival 
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3.1. Cell death 
Apoptosis is a ubiquitous homeostatic mechanism critical for the turnover of cells throughout the 
lifespan of multi-cellular organisms.  However, dysregulation of apoptosis occurs as either a 
cause or consequence of distinct pathologies that include neurodegenerative disorders (Fadeel 
and Orrenius 2005). The signaling pathways that regulate the progression of apoptosis have 
been extensively characterized and divided in two pathways. Induction of apoptosis via the 
extrinsic pathway is triggered by the activation of the death receptors leading to the activation of 
initiator caspases. (Lavrik et al. 2005). 
The intrinsic mitochondrial pathway of apoptosis is activated by a wide variety of stimuli that 
regulate the expression and function of the Bcl-2 (B-cell lymphoma 2) family of (anti or pro) 
apoptotic proteins. The BH3-only Bcl-2 family members (Bad, Bid, Bim and NOXA) regulate the 
anti-apoptotic Bcl-2 proteins (Bcl-2, Bcl-xl and Mcl-1) to promote apoptosis. The pro-apoptotic 
effector proteins Bax and Bak are sufficient and necessary for inducing the permeabilization of 
the outer mitochondrial membrane and the release of Cyt C (Figure 2.6). However, the 
activation of BH3-only proteins derepresses the direct inhibition of Bax and Bak by anti-
apoptotic Bcl-2 proteins. Released Cyt C leads to the recruitment of Apaf1 and caspase 9 into a 
platform (apoptosome) that activates caspase 9 and subsequently, executioner caspases 3, 6 
and 7. The extrinsic / death receptor pathway can crosstalk to the intrinsic / mitochondrial 
pathway of apoptosis by an amplification loop induced by caspase dependent 
cleavage/activation of Bid (Green and Llambi 2015). 
While a number of studies have reported the induction of apoptosis in astrocytes and microglia 
under different experimental conditions, very little evidence exists about the loss or 
degeneration of these glial cells with respect to human disorders. Conversely, oligodendrocytes 
are known to degenerate in demyelinating disorders such as multiple sclerosis, and to be 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
8 
 
affected directly or indirectly by the majority of known disorders in the CNS including ischemia, 
trauma and neurodegeneration. Glutamate/Ca2+ excitotoxicity, inflammation (cytokines) and 
oxidative stress are common triggers for oligodendrocyte injury in these pathological situations 
(Figure 1.4). Oligodendrocytes express ionotropic α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA)/kainite receptors whose activation induces Ca2+ overflow and 
apoptotic cell death via the intrinsic mitochondrial pathway via activation of Bax and caspase 3 
(Figure 1.4) (Ruiz et al. 2010; Sanchez-Gomez et al. 2011). The high lipid and iron content of 
oligodendrocytes also makes them susceptible to oxidative damage induced by cytokines 
(Zhang et al. 2005). 
3.2. Bioenergetics and metabolism 
Neurons are dependent on high rates of OXPHOS to meet their energy requirements, to 
maintain and restore ionic gradients, and for the uptake and recycling of neurotransmitters.  In 
contrast, astrocytes are highly glycolytic (Figure 2.1), but a large portion of glucose is converted 
to lactate and released to the extracellular space. Interestingly, glucose consumption in 
astrocytes exceeds their energy expenditure, which is explained by the astrocytes-neuron 
lactate shuttle hypothesis where lactate is shuttled from astrocytes (and oligodendrocytes) as a 
fuel for OXPHOS in neurons (Figure 1.1 and 2.2) (Belanger et al. 2011; Funfschilling et al. 
2012a; Lee et al. 2012; Morrison et al. 2013).  What limits OXPHOS in astrocytes? Recent 
studies have demonstrated that the activity of pyruvate dehydrogenase (PDH), which provides a 
route of entry for pyruvate into the tricarboxylic acid (TCA or Krebs) cycle, is reduced by its 
phosphorylation in astrocytes (Figure 1.1 and 2.3) (Halim et al. 2010). Interestingly, astrocytes 
have the same oxidative capacity as neurons, but are resilient to mitochondrial dysfunction (Di 
Monte et al. 1992).   
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
9 
 
Other carbon sources can fuel OXPHOS in astrocytes. Glutamate can be metabolized through 
the TCA cycle, but astrocytes primarily metabolize it to glutamine by the activity of glutamine 
synthase (GS) (Figure 2.4). However, when the extracellular concentration of glutamate 
increases to levels observed during synaptic transmission, the proportion of glutamate 
metabolized by the TCA cycle increases as well, while its conversion to glutamine decreases 
concomitantly (McKenna 2013; Nissen et al. 2015; Schousboe et al. 2014). Importantly, 
glutamate also exerts a stimulatory effect on glycolysis as well (Loaiza et al. 2003; Pellerin and 
Magistretti 1994). 
Acetate is also used as a carbon source by astrocytes, but its physiological significance has not 
been established (Belanger et al. 2011; Jiang et al. 2013). Astrocytes can oxidize free fatty 
acids (FFA) and ketone bodies, but neurons and oligodendrocytes can only use ketone bodies 
as these cell types would be highly vulnerable to ROS formation generated by FFA oxidation 
due to their high lipid content (Iglesias et al. 2016; Schonfeld and Reiser 2013). Twenty percent 
of total energy expenditure in the brain is linked to FFA oxidation (FAO), which occurs primarily 
in astrocytes (Ebert et al. 2003). As mentioned above, astrocytes exhibit high rates of OXPHOS 
(Lovatt et al. 2007), but a larger proportion of astrocyte PDH is phosphorylated compared to 
neuronal PDH, inhibiting the conversion of pyruvate to acetyl-CoA (Halim et al. 2010). Thus, 
FAO might actually be a major source for acetyl-CoA into the TCA cycle (Panov et al. 2014) 
(Figure 2.3). 
Oligodendrocytes have similar rates of glycolysis compared to astrocytes, but release less 
lactate since a larger proportion of pyruvate derived from glucose is metabolized via PDH into 
the TCA cycle. Similar to astrocytes, oligodendrocytes can carboxylate pyruvate to oxaloacetate 
via pyruvate carboxylase (PC) to replenish TCA intermediates (anaplerosis) or recycle pyruvate 
(Figure 2.3) (Amaral et al. 2016). In astrocytes however, pyruvate carboxylation also serves to 
compensate for the loss of TCA intermediates due to the generation of glutamate and 
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subsequently glutamine that is then shuttled to neurons (glutamate-glutamine cycle) (Figure 1.2 
and 2.4) (Schousboe et al. 2014). Lactate metabolism in oligodendrocytes has been 
demonstrated to participate in oligodendrocyte differentiation and myelination.(Rinholm et al. 
2011). Importantly, mitochondrial respiration / metabolism seems to be primarily involved in 
oligodendrocyte differentiation, while glycolysis appears to be sufficient to maintain post-
myelinated (differentiated) oligodendrocytes (Funfschilling et al. 2012b). Accordingly, 
demyelination disorders linked to mitochondrial dysfunction seem to be primarily linked to 
increased oxidative damage and changes in FFA metabolism but not energy failure (Lin et al. 
2012; Swalwell et al. 2011; Viader et al. 2013). 
3.3. Calcium 
Calcium (Ca2+) signaling is tightly coupled to its homeostasis. Ca2+ gradients across membranes 
and cellular compartments are established by the activity of Ca2+ pumps / transporters. The 
controlled activation of Ca2+ fluxes allows its release and the subsequent activation of a diverse 
array of signal transducers including kinases, enzymes and ion channels. Mitochondria are now 
recognized as important Ca2+ reservoirs or sinks. The regulation of Ca2+ signaling is not a 
simple process of its release and subsequent compartmentalization. Instead, it involves a highly 
localized release and controlled diffusion of Ca2+ across intracellular compartments and in most 
cases, the coordinated action of more than one Ca2+ reservoir and release / uptake system. The 
spatiotemporal complexity of this process is reflected by the existence of patterns of Ca2+ waves 
or sparks that are decoded by transducers selectively localized in different cellular 
compartments. Sequestration of Ca2+ within the mitochondrial matrix is partially driven by the 
negative environment generated by the extrusion of protons (H+) across the inner mitochondrial 
membrane by the ETC (Figure 2.3). Translocation of Ca2+ into the matrix is mediated by the 
mitochondrial Ca2+ uniporter (MCU) in an energy-independent manner (Figure 2.5). Ca2+ 
release from the mitochondria is mediated by Ca2+ exchangers (the sodium [Na+)]/Ca2+ [mNCX] 
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and mitochondrial proton [H+]/Ca2+ exchangers [mHCX]), or the opening of the mitochondrial 
permeability transition pore under pathological conditions (Figure 2.5). Importantly, 
mitochondria act as important buffers for Ca2+ release / influx from the endoplasmic reticulum 
(ER) and the plasma membrane that contribute to the regulation of Ca2+ signaling (Figure 2.5) 
(Rizzuto et al. 2012). 
Very little is known about the impact of mitochondrial Ca2+ homeostasis on glial signaling. 
However, as in other cell types, functional mitochondria in astrocytes and oligodendrocytes 
regulates Ca2+ waves generated by the activation of inositol 1,4,5-triphosphate (IP3) receptors 
(IP3R) and the release of Ca2+ from the ER (Boitier et al. 1999; Simpson and Russell 1996; 
Smith et al. 2005). Mitochondrial Ca2+ has also been shown to regulate vesicular glutamate 
release from astrocytes that modulates synaptic communication and excitability (Reyes and 
Parpura 2008). Ca2+ accumulation in mitochondria also modulates oxidative phosphorylation 
and energy production. PDH activity is regulated by a Ca2+-dependent dephosphorylation, while 
Ca2+ binding also regulates α-ketoglutarate (DKGDH)- and isocitrate (IDH)-dehydrogenase 
activity, which  increases NADH levels, electron flow and ATP synthesis (Figure 2.5) (Rizzuto et 
al. 2012). Accordingly, Ca2+ release from the ER stimulates mitochondrial-dependent energy 
production in astrocytes (Wu et al. 2007). Not only do mitochondria regulate Ca2+ accumulation 
and dynamics, but also its release. A recent report demonstrated that Ca2+ release via mNCX is 
coupled to store-operated Ca2+ entry (triggered by Ca2+ depletion from ER stores) and regulates 
astrocytes proliferation and excitotoxic glutamate release (Parnis et al. 2013). In microglia, 
mitochondrial Ca2+ influx via the mitochondrial transient receptor potential vanilloid 1 channel 
(TRPV1) depolarizes mitochondria resulting in mtROS production, mitogen activated protein 
kinase (MAPK) activation, and enhanced migration (Miyake et al. 2015). 
3.4. Inflammation 
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Inflammation is a key contributor to most neurological disorders. In a steady “basal” state, 
microglia performs continuous surveillance of the CNS, secrete neurotrophic factors, such as 
insulin-like growth factor 1 (IGF1), brain-derived neurotrophic factor (BDNF), transforming 
growth factor-β (TGFβ) and nerve growth factor (NGF), and promote synapse pruning for 
refinement of neuronal circuits during development.  Classical activation of microglia (M1) 
conveys the production of ROS and nitrogen species (RNS) and the release of pro-inflammatory 
cytokines (tumor necrosis factor [TNF] and interleukin-1β [IL-1β]) to promote brain tissue repair 
upon injury (removal of cell debris and restoring of tissue integrity) and, upon prolonged 
activation, neuronal dysfunction as well. Disease-associated factors such as xenobiotics, protein 
aggregates, and damage (DAMPs) or pathogen-associated molecular patterns (PAMPS) can 
activate microglia through a variety of surface receptors. These receptors include Toll-like 
receptors (for lipopolysacharide [LPS], oxidized low-density lipoprotein [LDL] and molecules 
released by damaged or dead cells including high-mobility group box 1 [HMGB1] and 
nucleotides), nucleotide-binding oligomerization domain (Nod)-like receptors (for amyloid 
proteins), advanced glycation end-products receptors or RAGE (that are also activated by 
HMGB1), and purinergic receptors (for purines and pyrimidines including nucleoside 
triphosphates, e.g. ATP) (Hu et al. 2014). Pro-inflammatory cytokines released from microglia 
also “activate” astrocytes, which might produce TNF to potentiate microglia activation as well. 
As such, co-cultures of microglia and astrocytes produce more neurotoxic factors than either 
activated cell type alone (Saijo and Glass 2011). Whether astrocytes can be activated in the 
absence of microglia is still unclear since most studies using primary cultures of astrocytes also 
contain at least 5% of microglia that significantly contribute to astrocyte activation (Facci et al. 
2014; Marinelli et al. 2015). The alternative (M2-like) phenotype of microglia is observed to be 
induced by transforming growth factor-β (TGFβ), IL-4, IL-6 and IL-10 secreted from glioma cells 
(Saijo and Glass 2011). 
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Mitochondrial dysfunction triggers inflammatory responses (West). During inflammation, 
changes in mitochondrial metabolism contribute to the activation of microglia. The M1 
phenotype of microglia was recently reported to be paralleled by a metabolic switch from 
mitochondrial OXPHOS to glycolysis that enhances carbon flux to the PPP (Figure 1.5) 
(Gimeno-Bayon et al. 2014; Orihuela et al. 2016; Voloboueva et al. 2013). Interestingly, 
inhibition of complex I activity activates microglial cells (Shaikh and Nicholson 2009; Ye et al. 
2016; Yuan et al. 2013), while impairment of mitochondrial fission reduces the production of pro-
inflammatory signals (Park et al. 2013). Induction of the M2-like phenotype results in no 
observable changes in mitochondrial oxygen consumption or lactate production (Orihuela et al. 
2016). However, mitochondrial toxins such as 3-nitropropionic acid and rotenone impair the 
transition to the M2 phenotype induced by IL-4 (Ferger et al. 2010). These results suggest that 
mitochondrial dysfunction in microglia can exacerbate the pro-inflammatory M1 phenotype and 
result in the release of neurotoxic pro-inflammatory cytokines, and enhanced ROS / RNS 
formation (Tang and Le 2016).  
3.5. Redox homeostasis and detoxification of xenobiotics 
In general, neurons have limited defense mechanisms against ROS compared to astrocytes. 
This enhanced resistance to oxidative damage in astrocytes is observed despite the fact that 
astrocytes have a deficient mitochondrial respiration and increased ROS formation when 
compared to neurons (Lopez-Fabuel et al. 2016). A comparative study also demonstrated that 
astrocytes are more resistant to oxidative damage than microglia or oligodendrocytes 
(Hollensworth et al. 2000). Astrocytes contain higher levels of endogenous antioxidants and 
antioxidant systems that include NADPH and G6PD (glucose-6-phosphate dehydrogenase). 
Astrocytes’ resistance to oxidative damage is explained by the activation of the antioxidant 
response via the nuclear factor erythroid-2-related factor 2 (Nrf2) transcription factor (Garcia-
Nogales et al. 2003; Shih et al. 2003). Both neurons and astrocytes can synthesize GSH, but 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
14 
 
neurons depend on the supply of GSH precursors from astrocytes (Figure 1.3). GSH is 
released from astrocytes via the ATP-binding cassette transporters subfamily C member 1 
transporter (ABCC1, or multidrug-resistance-associated protein 1 [MRP1]) (Hirrlinger and 
Dringen 2005). Extracellular GSH is then degraded by the γ-glutamyl transpeptidase (γGT) to 
produce l-cysteine-l-glycine (CysGly), which is cleaved further by the neuronal aminopeptidase 
N (ApN) into the amino acids glycine and cysteine that are taken up by neurons for de novo 
GSH synthesis (Figure 1.3) (Aoyama et al. 2008; Belanger et al. 2011). The glutamate-
glutamine cycle might also be involved in the regulation of the neuronal redox environment by 
astrocytes since GSH synthesis also requires glutamate. The importance of astrocytes for 
neuronal redox homeostasis was evidenced by a recent study demonstrating that conditional 
depletion of astrocytes promotes neuronal injury by oxidative stress (Schreiner et al. 2015). 
Astrocytes are also the first line of defense against xenobiotics entering into the brain since their 
extensions cover the external surface of capillaries as part of the blood brain barrier. 
Detoxification of electrophiles is dependent the formation of irreversible adducts with GSH that 
in many cases depends on the activity of glutathione-S-transferases (GST) and their efflux 
through MRPs (Dringen et al. 2015). 
But what is the role of mitochondria in redox homeostasis in astrocytes and neurons? The loss 
of GSH by its export to neurons or due to the detoxification of electrophiles is expected to 
prompt astrocytes to replenish GSH precursors. Interestingly, GSH depletion upregulates 
mitochondrial activity in astrocytes (Vasquez et al. 2001) and we have recently observed that 
mitochondrial OXPHOS is essential for the detoxification of electrophiles via the GSH/MRP 
system (manuscript in preparation), but the exact mechanisms that regulate this phenomenon 
are still unclear. 
4. Conclusions and Perspectives 
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Mitochondrial dysfunction has been widely recognized as central to the pathogenesis of 
neurological disorders. However, the majority of current research efforts have been focused on 
understanding the causes and consequences of mitochondrial dysfunction in neuronal cells that 
rely on OXPHOS to generate energy and are also more sensitive to mitochondrial ROS 
formation. Less is known about the functional role of mitochondria in glial cells and its 
implications for neuronal survival and brain function. In this work, we have provided an overview 
of the role of mitochondria in glial cell function that includes metabolism, redox homeostasis, 
Ca2+ signaling, inflammation and cell death. The evidence so far clearly demonstrates the 
importance of mitochondrial health in glial cells and its relevance to neuronal function. 
Nevertheless, this review also highlights our limited understanding of mitochondria function in 
glial cells and the need for further investigations in this area that is expanding. For example, 
recent studies have demonstrated that damaged mitochondria can be transferred from neuronal 
axons for their turnover in astrocytes (Davis et al. 2014), and conversely, astrocytes have been 
shown to transfer mitochondria to promote neuronal survival (Hayakawa et al. 2016) (Figure 
1.3). Many questions remain to be answered regarding the role of mitochondrial in neurological 
disorders, but it is time for us to think about mitochondrial health and dysfunction in a more 
inclusive context outside neuronal cells. 
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Figure Legends 
Figure 1. Neuronal metabolism, redox homeostasis and signaling are supported by neighboring 
glial cells. 1.1: Glucose and lactate enter the brain through Glut1 (glucose transporter 1) and 
MCT1 (monocarboxylate transporter 1) transporters in the vascular epithelium. Glucose (Glut3) 
and lactate (MCT1 or 2) are uptaken from the extracellular space by neuronal calls to fuel the 
TCA cycle for the generation of ATP and biosynthesis of essential molecules. 1.2: As a 
component of the blood brain barrier (BBB), astrocytes uptake glucose from the capillary 
epithelium via Glut1 as well, converting the majority of pyruvate (Pyr) generated into lactate 
which is exported by MCT1. Astrocytes also uptake the neurotransmitter glutamate (Glu) from 
the synaptic cleft via EAAT (excitatory amino acid transporters) to be (a) converted into 
glutamine (Gln), (b) exchanged for extracellular cystine (Cys) by xCT, (c) feed into the TCA 
cycle, or (d) for GSH synthesis. Astrocytes form extended networks with other glia 
(oligodendrocytes and astrocytes) via gap junctions, sharing nutrients and molecular 
components with cells more distal to the capillaries. 1.3: Astrocytes contribute to the redox state 
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of neuronal cells by exporting GSH via MRP1 which is broken down by γGT and ApN into its 
amino acid components to be uptaken and reassembled as GSH in neuronal cells. 
Dysfunctional or damaged mitochondrial, likely capable of generating ROS, are transferred from 
neurons to astrocytes to be degraded by mitophagy. 1.4: Oligodendrocytes wrap neuronal 
projections (myelin sheaths) improving signal conduction and like astrocytes, have been 
proposed to shuttle lactate to the neurons. 1.5: Microglia are activated by a variety of factors, 
including cytokines, oxidized proteins, and protein aggregates. Activated microglia migrate to 
the site of damage and can induce neuronal or oligodendrocyte cell death through the release of 
cytokines, and the generation of ROS via NADPH oxidases (NOX) and nitric oxide synthases 
(NOS). AA-T, amino acid transporters; LDH1 or 5, lactate dehydrogenase isoform 1 or 5. 
Figure 2. Mitochondrial metabolism and signaling in astrocytes. 2.1: Glucose in astrocytes is 
used for glycogenesis, NADPH production through the PPP, or glycolysis. Astrocytes are highly 
glycolytic due to the expression of high levels of 6‐phosphofructo‐2‐kinase / 
fructose‐2,6‐bisphosphatase‐3 (PFKFB3), whose byproduct fructose‐2,6‐bisphosphate 
(F2,6P2), is a positive effector  of the glycolytic enzyme 6‐phosphofructo‐1‐kinase (PFK1). In 
addition, the activity of PFKFB3 is increased by phosphorylation by 5′‐AMP‐activated protein 
kinase (AMPK) (Bolanos 2016). 2.2: Astrocytes primarily derive ATP from glycolysis rather than 
oxidative phosphorylation, where pyruvate is converted to lactate by LDH5 and exported to the 
extracellular space to be consumed by neurons. 2.3: Astrocytes carboxylate pyruvate to 
oxaloacetate (OAA) via pyruvate carboxylase (PC) to regenerate TCA cycle intermediates. 
Phosphorylation of pyruvate dehydrogenase (PDH) restricts the conversion of pyruvate to 
acetyl-CoA (Ac-CoA). Thus, FAO has been proposed to be the primary contributor of Ac-CoA to 
the TCA cycle. 2.4: Alpha ketoglutarate (αKG) generated from the TCA cycle can be transported 
to the cytosol and converted to Glu by glutamic-oxaloacetic transaminase 1 or aspartate (Asp) 
aminotransferase (GOT1) as part of the malate-Asp shuttle. Glu has three central metabolic 
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pathways in astrocytes. 1) Glu can be converted to Gln by GS and exported to neurons by the 
sodium-coupled neutral amino acid transporter 3 (SNAT3). 2) Glu is exchanged via xCT for 
extracellular cystine that is reduced to Cys. Extracellular Glu can be uptaken back by astrocytes 
by EAAT1/2. Finally, 3) Glu, Gly and Cys are precursors of GSH, which is also exported to 
neurons via MRP1. 2.5: The ER acts as a store for intracellular calcium, where the 
sarco/endoplasmic reticulum calcium ion ATPase (SERCA) pumps cytosolic Ca2+ into the ER. 
Ca2+ signaling is tightly regulated by the activation of IP3R that release Ca2+ from ER stores, as 
well as by the activation of plasma membrane Ca2+ channels. Mitochondria can buffer Ca2+ by 
its transport across the inner mitochondrial membrane to the matrix viaMCU), while the export is 
performed by mNCX and mHCX. Mitochondria can also transport Ca2+ in and out of the 
mitochondria via the activation of distinct Ca2+ permeable channels. In the matrix, Ca2+ 
stimulates TCA carbon flux by binding to PDH, IDH, and αKGDH, increasing the activity of the 
ETC and ATP production. 2.6: Cyt C is held close to the inner mitochondrial membrane by 
cardiolipin (not shown), acting as a component of ETC. Dissociation of Cyt C from cardiolipin, 
through oxidative or enzymatic means, coupled with permeabilization of the outer mitochondrial 
membrane by the formation of Bax/Bak oligomeric channels, allows Cyt C to escape into the 
cytosol. Cytosolic Cyt C associates with apoptotic protease-activating factor 1 (APAF1), forming 
the apoptosome and leading to the activation of caspases to initiate apoptosis. AGC, aspartate-
glutamate carrier; CPT1 or 2, carnitine palmitoyltransferase isoform 1 or 2; MDH1 or 2, malate 
dehydrogenase isoform 1 or 2; MPC1, mitochondrial pyruvate carrier 1; OGC, 2-oxoglutarate (α-
ketoglutarate) carrier. 
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Abstract 
Mitochondrial dysfunction is central to the pathogenesis of neurological disorders. Neurons rely 
on oxidative phosphorylation to meet their energy requirements and thus alterations in 
mitochondrial function are linked to energy failure and neuronal cell death. Furthermore, 
dysfunctional mitochondria are reported to increase the steady-state levels of reactive oxygen 
species derived from the leakage of electrons from the electron transport chain. Research 
aimed at understanding mitochondrial dysfunction and its role in neurological disorders has 
been primarily geared towards neurons. In contrast, the role that dysfunctional mitochondria 
have in glial cells’ function and its implication for neuronal homeostasis and brain function has 
been largely understudied. Except for oligodendrocytes, astrocytes and microglia do not 
degenerate upon the impairment of mitochondrial function, as they rely primarily on glycolysis to 
produce energy and have a higher antioxidant capacity than neurons. However, recent evidence 
highlights the role of mitochondrial metabolism and signaling in glial cell function. In this work, 
we review the functional role of mitochondria in glial cells and the evidence regarding its 
potential role regulating neuronal homeostasis and disease progression.  
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1. Introduction 
Mitochondria are involved in a myriad of other processes relevant for cell function besides 
energy (ATP) production (Yin et al. 2014), making them more than simply powerhouses of the 
cell. Mitochondria are a hub for signaling processes that include the maintenance of calcium 
(Ca2+) homeostasis and the formation of signaling molecules and thus, signaling events (Bonini ; 
Chandel 2015).  For example, cell death progression is well known to be triggered by the 
release of mitochondrial pro-death proteins.  Alterations in mitochondrial functions are expected 
to have important implications for cellular function and disease progression. Correspondingly, 
numerous pathological conditions have been connected to mitochondrial dysfunction. 
Neuronal cell death in brain disorders (neurodegeneration) and injury (neurotoxicity and 
ischemia) has been linked to a variety of alterations in mitochondrial homeostasis/function 
including traffic, quality control and turnover, homeostasis (bioenergetics and electron transport)  
and signaling (metabolism and Ca2+ handling) (Chaturvedi and Flint Beal 2013; Yin et al. 2014). 
Compared to other cell types, neurons are more dependent on mitochondrial oxidative 
phosphorylation (OXPHOS) to fulfill their energy demands. Mitochondrial dysfunction with the 
concomitant energy failure and increased generation of reactive oxygen species (ROS) are 
considered central to neuronal cell loss in brain disorders because neurons have a limited 
capacity to upregulate glycolysis or to counteract oxidative damage (Fernandez-Fernandez et 
al. 2012; Herrero-Mendez et al. 2009). As such, research has been primarily directed at 
understanding the causes and consequences of mitochondrial dysfunction in neuronal 
populations affected during neurodegeneration or brain injury (Moran et al. 2012; Yin et al. 
2014). 
While initially considered as accessory cells to neurons, glial cells are now recognized to be 
essential for neuronal cell homeostasis, survival and proper brain function and development 
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(Bolanos 2016; Fernandez-Fernandez et al. 2012; Kubik and Philbert 2015). Importantly, 
genetic modifications or xenobiotics (i.e. pesticides [rotenone or paraquat], metals [lead, 
arsenic], antibiotics and drugs that target the integrity of mitochondrial DNA) recognized to alter 
mitochondrial function in neurons are expected to alter mitochondrial function in glial cells as 
well (Ballinger ; Chan ; Kubik and Philbert 2015; Meyer et al. 2013). Unfortunately, very few 
studies have addressed the pathological implications of mitochondrial dysfunction in glial cells 
and its consequences in neurological disorders. Herein, we review the current evidence 
demonstrating the importance of mitochondrial homeostasis and signaling in glial function and 
how their functional deficiency has important implications for brain disorders and injury that lead 
to or are a consequence of neuronal cell death. 
2. Glial cell types and their functional roles 
Glial cells can be generally classified as macroglia (astrocytes and oligodendrocytes) or 
microglia. Macroglia originate from the embryonic ectoderm, while microglia originate from the 
mesoderm and enter the vertebrate brain during embryogenesis. While initially grouped under 
the term “glia” (Greek term for glue), it is now clearly established that glial cells regulate a 
number of physiological processes required for proper neuronal survival and brain function. 
Refinement and revision of counting techniques have demonstrated that while the overall ratio 
of neurons to glial varies between different regions in the brain, a ratio of ~1:1 glia to neuron 
exists in the entire human brain, which is significantly smaller than previous estimates (~10:1). 
Oligodendrocytes are reported to be the most abundant type of glial cells (45–75%), followed by 
astrocytes (19–40%), and microglia (10% or less) (von Bartheld et al. 2016). 
Oligodendrocytes are responsible for axon myelination at large membrane extensions, providing 
axons with an “insulating coat” that enhances nerve impulse conduction (Figure 1.4). 
Oligodendrocytes have several extensions that form several internodal segments of myelin 
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separated by gaps (Ranvier nodes) (Baumann and Pham-Dinh 2001; Snell 2010). 
Oligodendrocytes are found in both gray and white matter, but are a major fraction of all the 
cells in white matter.  
Astrocytes are small cells with processes that are radially arranged, and have considerable 
molecular, structural, and functional diversity at the regional level. Astrocyte extensions cover 
the external surface of brain capillaries (perivascular feet), the synaptic cleft between the pre-
synaptic and the post-synaptic terminals, and the bare segments of axons at the Ranvier nodes 
(Figure 1.2). Astrocytes also form highly organized domains interconnected via gap junctions 
with other astrocytes and oligodendrocytes (Figure 1.2). Additionally, astrocytes regulate 
neurotransmitter levels in the synaptic cleft, provide neurons with energetic and antioxidant 
precursors (Figure 1.2), play an important role in neuro/synaptogenesis and tissue repair, and 
also regulate blood flow and inflammatory processes by the release of signaling mediators 
(Sofroniew and Vinters 2010).  
Microglial cells are resident macrophages distributed throughout the central nervous system 
(CNS) (Byrne and Roberts 2009). As innate immune cells, microglia are activated by infection, 
tissue injury, or xenobiotics. Upon activation, microglia cells retract their cytoplasmic extensions 
and migrate to the site of injury, where they proliferate and become antigen presenting cells. 
Microglia phagocytose degenerating cells and act as sources of immunoregulatory and 
neuromodulatory factors such as cytokines, chemokines and neurotrophic factors. Microglia can 
be activated by cell-surface receptors for endotoxins, cytokines, chemokines, misfolded 
proteins, serum factors and ATP (Figure 1.5). While mild activation is a key adaptive immune 
response, continuous activation or overactivation of microglia is thought to contribute to 
neurodegeneration (Finsen and Owens 2011; Hanisch 2013; Hanisch and Kettenmann 2007).  
3. Mitochondrial dysfunction in glial cells and its effect on neuronal function/survival 
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3.1. Cell death 
Apoptosis is a ubiquitous homeostatic mechanism critical for the turnover of cells throughout the 
lifespan of multi-cellular organisms.  However, dysregulation of apoptosis occurs as either a 
cause or consequence of distinct pathologies that include neurodegenerative disorders (Fadeel 
and Orrenius 2005). The signaling pathways that regulate the progression of apoptosis have 
been extensively characterized and divided in two pathways. Induction of apoptosis via the 
extrinsic pathway is triggered by the activation of the death receptors leading to the activation of 
initiator caspases. (Lavrik et al. 2005). 
The intrinsic mitochondrial pathway of apoptosis is activated by a wide variety of stimuli that 
regulate the expression and function of the Bcl-2 (B-cell lymphoma 2) family of (anti or pro) 
apoptotic proteins. The BH3-only Bcl-2 family members (Bad, Bid, Bim and NOXA) regulate the 
anti-apoptotic Bcl-2 proteins (Bcl-2, Bcl-xl and Mcl-1) to promote apoptosis. The pro-apoptotic 
effector proteins Bax and Bak are sufficient and necessary for inducing the permeabilization of 
the outer mitochondrial membrane and the release of Cyt C (Figure 2.6). However, the 
activation of BH3-only proteins derepresses the direct inhibition of Bax and Bak by anti-
apoptotic Bcl-2 proteins. Released Cyt C leads to the recruitment of Apaf1 and caspase 9 into a 
platform (apoptosome) that activates caspase 9 and subsequently, executioner caspases 3, 6 
and 7. The extrinsic / death receptor pathway can crosstalk to the intrinsic / mitochondrial 
pathway of apoptosis by an amplification loop induced by caspase dependent 
cleavage/activation of Bid (Green and Llambi 2015). 
While a number of studies have reported the induction of apoptosis in astrocytes and microglia 
under different experimental conditions, very little evidence exists about the loss or 
degeneration of these glial cells with respect to human disorders. Conversely, oligodendrocytes 
are known to degenerate in demyelinating disorders such as multiple sclerosis, and to be 
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affected directly or indirectly by the majority of known disorders in the CNS including ischemia, 
trauma and neurodegeneration. Glutamate/Ca2+ excitotoxicity, inflammation (cytokines) and 
oxidative stress are common triggers for oligodendrocyte injury in these pathological situations 
(Figure 1.4). Oligodendrocytes express ionotropic α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA)/kainite receptors whose activation induces Ca2+ overflow and 
apoptotic cell death via the intrinsic mitochondrial pathway via activation of Bax and caspase 3 
(Figure 1.4) (Ruiz et al. 2010; Sanchez-Gomez et al. 2011). The high lipid and iron content of 
oligodendrocytes also makes them susceptible to oxidative damage induced by cytokines 
(Zhang et al. 2005). 
3.2. Bioenergetics and metabolism 
Neurons are dependent on high rates of OXPHOS to meet their energy requirements, to 
maintain and restore ionic gradients, and for the uptake and recycling of neurotransmitters.  In 
contrast, astrocytes are highly glycolytic (Figure 2.1), but a large portion of glucose is converted 
to lactate and released to the extracellular space. Interestingly, glucose consumption in 
astrocytes exceeds their energy expenditure, which is explained by the astrocytes-neuron 
lactate shuttle hypothesis where lactate is shuttled from astrocytes (and oligodendrocytes) as a 
fuel for OXPHOS in neurons (Figure 1.1 and 2.2) (Belanger et al. 2011; Funfschilling et al. 
2012a; Lee et al. 2012; Morrison et al. 2013).  What limits OXPHOS in astrocytes? Recent 
studies have demonstrated that the activity of pyruvate dehydrogenase (PDH), which provides a 
route of entry for pyruvate into the tricarboxylic acid (TCA or Krebs) cycle, is reduced by its 
phosphorylation in astrocytes (Figure 1.1 and 2.3) (Halim et al. 2010). Interestingly, astrocytes 
have the same oxidative capacity as neurons, but are resilient to mitochondrial dysfunction (Di 
Monte et al. 1992).   
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Other carbon sources can fuel OXPHOS in astrocytes. Glutamate can be metabolized through 
the TCA cycle, but astrocytes primarily metabolize it to glutamine by the activity of glutamine 
synthase (GS) (Figure 2.4). However, when the extracellular concentration of glutamate 
increases to levels observed during synaptic transmission, the proportion of glutamate 
metabolized by the TCA cycle increases as well, while its conversion to glutamine decreases 
concomitantly (McKenna 2013; Nissen et al. 2015; Schousboe et al. 2014). Importantly, 
glutamate also exerts a stimulatory effect on glycolysis as well (Loaiza et al. 2003; Pellerin and 
Magistretti 1994). 
Acetate is also used as a carbon source by astrocytes, but its physiological significance has not 
been established (Belanger et al. 2011; Jiang et al. 2013). Astrocytes can oxidize free fatty 
acids (FFA) and ketone bodies, but neurons and oligodendrocytes can only use ketone bodies 
as these cell types would be highly vulnerable to ROS formation generated by FFA oxidation 
due to their high lipid content (Iglesias et al. 2016; Schonfeld and Reiser 2013). Twenty percent 
of total energy expenditure in the brain is linked to FFA oxidation (FAO), which occurs primarily 
in astrocytes (Ebert et al. 2003). As mentioned above, astrocytes exhibit high rates of OXPHOS 
(Lovatt et al. 2007), but a larger proportion of astrocyte PDH is phosphorylated compared to 
neuronal PDH, inhibiting the conversion of pyruvate to acetyl-CoA (Halim et al. 2010). Thus, 
FAO might actually be a major source for acetyl-CoA into the TCA cycle (Panov et al. 2014) 
(Figure 2.3). 
Oligodendrocytes have similar rates of glycolysis compared to astrocytes, but release less 
lactate since a larger proportion of pyruvate derived from glucose is metabolized via PDH into 
the TCA cycle. Similar to astrocytes, oligodendrocytes can carboxylate pyruvate to oxaloacetate 
via pyruvate carboxylase (PC) to replenish TCA intermediates (anaplerosis) or recycle pyruvate 
(Figure 2.3) (Amaral et al. 2016). In astrocytes however, pyruvate carboxylation also serves to 
compensate for the loss of TCA intermediates due to the generation of glutamate and 
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subsequently glutamine that is then shuttled to neurons (glutamate-glutamine cycle) (Figure 1.2 
and 2.4) (Schousboe et al. 2014). Lactate metabolism in oligodendrocytes has been 
demonstrated to participate in oligodendrocyte differentiation and myelination.(Rinholm et al. 
2011). Importantly, mitochondrial respiration / metabolism seems to be primarily involved in 
oligodendrocyte differentiation, while glycolysis appears to be sufficient to maintain post-
myelinated (differentiated) oligodendrocytes (Funfschilling et al. 2012b). Accordingly, 
demyelination disorders linked to mitochondrial dysfunction seem to be primarily linked to 
increased oxidative damage and changes in FFA metabolism but not energy failure (Lin et al. 
2012; Swalwell et al. 2011; Viader et al. 2013). 
3.3. Calcium 
Calcium (Ca2+) signaling is tightly coupled to its homeostasis. Ca2+ gradients across membranes 
and cellular compartments are established by the activity of Ca2+ pumps / transporters. The 
controlled activation of Ca2+ fluxes allows its release and the subsequent activation of a diverse 
array of signal transducers including kinases, enzymes and ion channels. Mitochondria are now 
recognized as important Ca2+ reservoirs or sinks. The regulation of Ca2+ signaling is not a 
simple process of its release and subsequent compartmentalization. Instead, it involves a highly 
localized release and controlled diffusion of Ca2+ across intracellular compartments and in most 
cases, the coordinated action of more than one Ca2+ reservoir and release / uptake system. The 
spatiotemporal complexity of this process is reflected by the existence of patterns of Ca2+ waves 
or sparks that are decoded by transducers selectively localized in different cellular 
compartments. Sequestration of Ca2+ within the mitochondrial matrix is partially driven by the 
negative environment generated by the extrusion of protons (H+) across the inner mitochondrial 
membrane by the ETC (Figure 2.3). Translocation of Ca2+ into the matrix is mediated by the 
mitochondrial Ca2+ uniporter (MCU) in an energy-independent manner (Figure 2.5). Ca2+ 
release from the mitochondria is mediated by Ca2+ exchangers (the sodium [Na+)]/Ca2+ [mNCX] 
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and mitochondrial proton [H+]/Ca2+ exchangers [mHCX]), or the opening of the mitochondrial 
permeability transition pore under pathological conditions (Figure 2.5). Importantly, 
mitochondria act as important buffers for Ca2+ release / influx from the endoplasmic reticulum 
(ER) and the plasma membrane that contribute to the regulation of Ca2+ signaling (Figure 2.5) 
(Rizzuto et al. 2012). 
Very little is known about the impact of mitochondrial Ca2+ homeostasis on glial signaling. 
However, as in other cell types, functional mitochondria in astrocytes and oligodendrocytes 
regulates Ca2+ waves generated by the activation of inositol 1,4,5-triphosphate (IP3) receptors 
(IP3R) and the release of Ca2+ from the ER (Boitier et al. 1999; Simpson and Russell 1996; 
Smith et al. 2005). Mitochondrial Ca2+ has also been shown to regulate vesicular glutamate 
release from astrocytes that modulates synaptic communication and excitability (Reyes and 
Parpura 2008). Ca2+ accumulation in mitochondria also modulates oxidative phosphorylation 
and energy production. PDH activity is regulated by a Ca2+-dependent dephosphorylation, while 
Ca2+ binding also regulates α-ketoglutarate (DKGDH)- and isocitrate (IDH)-dehydrogenase 
activity, which  increases NADH levels, electron flow and ATP synthesis (Figure 2.5) (Rizzuto et 
al. 2012). Accordingly, Ca2+ release from the ER stimulates mitochondrial-dependent energy 
production in astrocytes (Wu et al. 2007). Not only do mitochondria regulate Ca2+ accumulation 
and dynamics, but also its release. A recent report demonstrated that Ca2+ release via mNCX is 
coupled to store-operated Ca2+ entry (triggered by Ca2+ depletion from ER stores) and regulates 
astrocytes proliferation and excitotoxic glutamate release (Parnis et al. 2013). In microglia, 
mitochondrial Ca2+ influx via the mitochondrial transient receptor potential vanilloid 1 channel 
(TRPV1) depolarizes mitochondria resulting in mtROS production, mitogen activated protein 
kinase (MAPK) activation, and enhanced migration (Miyake et al. 2015). 
3.4. Inflammation 
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Inflammation is a key contributor to most neurological disorders. In a steady “basal” state, 
microglia performs continuous surveillance of the CNS, secrete neurotrophic factors, such as 
insulin-like growth factor 1 (IGF1), brain-derived neurotrophic factor (BDNF), transforming 
growth factor-β (TGFβ) and nerve growth factor (NGF), and promote synapse pruning for 
refinement of neuronal circuits during development.  Classical activation of microglia (M1) 
conveys the production of ROS and nitrogen species (RNS) and the release of pro-inflammatory 
cytokines (tumor necrosis factor [TNF] and interleukin-1β [IL-1β]) to promote brain tissue repair 
upon injury (removal of cell debris and restoring of tissue integrity) and, upon prolonged 
activation, neuronal dysfunction as well. Disease-associated factors such as xenobiotics, protein 
aggregates, and damage (DAMPs) or pathogen-associated molecular patterns (PAMPS) can 
activate microglia through a variety of surface receptors. These receptors include Toll-like 
receptors (for lipopolysacharide [LPS], oxidized low-density lipoprotein [LDL] and molecules 
released by damaged or dead cells including high-mobility group box 1 [HMGB1] and 
nucleotides), nucleotide-binding oligomerization domain (Nod)-like receptors (for amyloid 
proteins), advanced glycation end-products receptors or RAGE (that are also activated by 
HMGB1), and purinergic receptors (for purines and pyrimidines including nucleoside 
triphosphates, e.g. ATP) (Hu et al. 2014). Pro-inflammatory cytokines released from microglia 
also “activate” astrocytes, which might produce TNF to potentiate microglia activation as well. 
As such, co-cultures of microglia and astrocytes produce more neurotoxic factors than either 
activated cell type alone (Saijo and Glass 2011). Whether astrocytes can be activated in the 
absence of microglia is still unclear since most studies using primary cultures of astrocytes also 
contain at least 5% of microglia that significantly contribute to astrocyte activation (Facci et al. 
2014; Marinelli et al. 2015). The alternative (M2-like) phenotype of microglia is observed to be 
induced by transforming growth factor-β (TGFβ), IL-4, IL-6 and IL-10 secreted from glioma cells 
(Saijo and Glass 2011). 
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Mitochondrial dysfunction triggers inflammatory responses (West). During inflammation, 
changes in mitochondrial metabolism contribute to the activation of microglia. The M1 
phenotype of microglia was recently reported to be paralleled by a metabolic switch from 
mitochondrial OXPHOS to glycolysis that enhances carbon flux to the PPP (Figure 1.5) 
(Gimeno-Bayon et al. 2014; Orihuela et al. 2016; Voloboueva et al. 2013). Interestingly, 
inhibition of complex I activity activates microglial cells (Shaikh and Nicholson 2009; Ye et al. 
2016; Yuan et al. 2013), while impairment of mitochondrial fission reduces the production of pro-
inflammatory signals (Park et al. 2013). Induction of the M2-like phenotype results in no 
observable changes in mitochondrial oxygen consumption or lactate production (Orihuela et al. 
2016). However, mitochondrial toxins such as 3-nitropropionic acid and rotenone impair the 
transition to the M2 phenotype induced by IL-4 (Ferger et al. 2010). These results suggest that 
mitochondrial dysfunction in microglia can exacerbate the pro-inflammatory M1 phenotype and 
result in the release of neurotoxic pro-inflammatory cytokines, and enhanced ROS / RNS 
formation (Tang and Le 2016).  
3.5. Redox homeostasis and detoxification of xenobiotics 
In general, neurons have limited defense mechanisms against ROS compared to astrocytes. 
This enhanced resistance to oxidative damage in astrocytes is observed despite the fact that 
astrocytes have a deficient mitochondrial respiration and increased ROS formation when 
compared to neurons (Lopez-Fabuel et al. 2016). A comparative study also demonstrated that 
astrocytes are more resistant to oxidative damage than microglia or oligodendrocytes 
(Hollensworth et al. 2000). Astrocytes contain higher levels of endogenous antioxidants and 
antioxidant systems that include NADPH and G6PD (glucose-6-phosphate dehydrogenase). 
Astrocytes’ resistance to oxidative damage is explained by the activation of the antioxidant 
response via the nuclear factor erythroid-2-related factor 2 (Nrf2) transcription factor (Garcia-
Nogales et al. 2003; Shih et al. 2003). Both neurons and astrocytes can synthesize GSH, but 
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neurons depend on the supply of GSH precursors from astrocytes (Figure 1.3). GSH is 
released from astrocytes via the ATP-binding cassette transporters subfamily C member 1 
transporter (ABCC1, or multidrug-resistance-associated protein 1 [MRP1]) (Hirrlinger and 
Dringen 2005). Extracellular GSH is then degraded by the γ-glutamyl transpeptidase (γGT) to 
produce l-cysteine-l-glycine (CysGly), which is cleaved further by the neuronal aminopeptidase 
N (ApN) into the amino acids glycine and cysteine that are taken up by neurons for de novo 
GSH synthesis (Figure 1.3) (Aoyama et al. 2008; Belanger et al. 2011). The glutamate-
glutamine cycle might also be involved in the regulation of the neuronal redox environment by 
astrocytes since GSH synthesis also requires glutamate. The importance of astrocytes for 
neuronal redox homeostasis was evidenced by a recent study demonstrating that conditional 
depletion of astrocytes promotes neuronal injury by oxidative stress (Schreiner et al. 2015). 
Astrocytes are also the first line of defense against xenobiotics entering into the brain since their 
extensions cover the external surface of capillaries as part of the blood brain barrier. 
Detoxification of electrophiles is dependent the formation of irreversible adducts with GSH that 
in many cases depends on the activity of glutathione-S-transferases (GST) and their efflux 
through MRPs (Dringen et al. 2015). 
But what is the role of mitochondria in redox homeostasis in astrocytes and neurons? The loss 
of GSH by its export to neurons or due to the detoxification of electrophiles is expected to 
prompt astrocytes to replenish GSH precursors. Interestingly, GSH depletion upregulates 
mitochondrial activity in astrocytes (Vasquez et al. 2001) and we have recently observed that 
mitochondrial OXPHOS is essential for the detoxification of electrophiles via the GSH/MRP 
system (manuscript in preparation), but the exact mechanisms that regulate this phenomenon 
are still unclear. 
4. Conclusions and Perspectives 
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Mitochondrial dysfunction has been widely recognized as central to the pathogenesis of 
neurological disorders. However, the majority of current research efforts have been focused on 
understanding the causes and consequences of mitochondrial dysfunction in neuronal cells that 
rely on OXPHOS to generate energy and are also more sensitive to mitochondrial ROS 
formation. Less is known about the functional role of mitochondria in glial cells and its 
implications for neuronal survival and brain function. In this work, we have provided an overview 
of the role of mitochondria in glial cell function that includes metabolism, redox homeostasis, 
Ca2+ signaling, inflammation and cell death. The evidence so far clearly demonstrates the 
importance of mitochondrial health in glial cells and its relevance to neuronal function. 
Nevertheless, this review also highlights our limited understanding of mitochondria function in 
glial cells and the need for further investigations in this area that is expanding. For example, 
recent studies have demonstrated that damaged mitochondria can be transferred from neuronal 
axons for their turnover in astrocytes (Davis et al. 2014), and conversely, astrocytes have been 
shown to transfer mitochondria to promote neuronal survival (Hayakawa et al. 2016) (Figure 
1.3). Many questions remain to be answered regarding the role of mitochondrial in neurological 
disorders, but it is time for us to think about mitochondrial health and dysfunction in a more 
inclusive context outside neuronal cells. 
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Figure Legends 
Figure 1. Neuronal metabolism, redox homeostasis and signaling are supported by neighboring 
glial cells. 1.1: Glucose and lactate enter the brain through Glut1 (glucose transporter 1) and 
MCT1 (monocarboxylate transporter 1) transporters in the vascular epithelium. Glucose (Glut3) 
and lactate (MCT1 or 2) are uptaken from the extracellular space by neuronal calls to fuel the 
TCA cycle for the generation of ATP and biosynthesis of essential molecules. 1.2: As a 
component of the blood brain barrier (BBB), astrocytes uptake glucose from the capillary 
epithelium via Glut1 as well, converting the majority of pyruvate (Pyr) generated into lactate 
which is exported by MCT1. Astrocytes also uptake the neurotransmitter glutamate (Glu) from 
the synaptic cleft via EAAT (excitatory amino acid transporters) to be (a) converted into 
glutamine (Gln), (b) exchanged for extracellular cystine (Cys) by xCT, (c) feed into the TCA 
cycle, or (d) for GSH synthesis. Astrocytes form extended networks with other glia 
(oligodendrocytes and astrocytes) via gap junctions, sharing nutrients and molecular 
components with cells more distal to the capillaries. 1.3: Astrocytes contribute to the redox state 
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of neuronal cells by exporting GSH via MRP1 which is broken down by γGT and ApN into its 
amino acid components to be uptaken and reassembled as GSH in neuronal cells. 
Dysfunctional or damaged mitochondrial, likely capable of generating ROS, are transferred from 
neurons to astrocytes to be degraded by mitophagy. 1.4: Oligodendrocytes wrap neuronal 
projections (myelin sheaths) improving signal conduction and like astrocytes, have been 
proposed to shuttle lactate to the neurons. 1.5: Microglia are activated by a variety of factors, 
including cytokines, oxidized proteins, and protein aggregates. Activated microglia migrate to 
the site of damage and can induce neuronal or oligodendrocyte cell death through the release of 
cytokines, and the generation of ROS via NADPH oxidases (NOX) and nitric oxide synthases 
(NOS). AA-T, amino acid transporters; LDH1 or 5, lactate dehydrogenase isoform 1 or 5. 
Figure 2. Mitochondrial metabolism and signaling in astrocytes. 2.1: Glucose in astrocytes is 
used for glycogenesis, NADPH production through the PPP, or glycolysis. Astrocytes are highly 
glycolytic due to the expression of high levels of 6‐phosphofructo‐2‐kinase / 
fructose‐2,6‐bisphosphatase‐3 (PFKFB3), whose byproduct fructose‐2,6‐bisphosphate 
(F2,6P2), is a positive effector  of the glycolytic enzyme 6‐phosphofructo‐1‐kinase (PFK1). In 
addition, the activity of PFKFB3 is increased by phosphorylation by 5′‐AMP‐activated protein 
kinase (AMPK) (Bolanos 2016). 2.2: Astrocytes primarily derive ATP from glycolysis rather than 
oxidative phosphorylation, where pyruvate is converted to lactate by LDH5 and exported to the 
extracellular space to be consumed by neurons. 2.3: Astrocytes carboxylate pyruvate to 
oxaloacetate (OAA) via pyruvate carboxylase (PC) to regenerate TCA cycle intermediates. 
Phosphorylation of pyruvate dehydrogenase (PDH) restricts the conversion of pyruvate to 
acetyl-CoA (Ac-CoA). Thus, FAO has been proposed to be the primary contributor of Ac-CoA to 
the TCA cycle. 2.4: Alpha ketoglutarate (αKG) generated from the TCA cycle can be transported 
to the cytosol and converted to Glu by glutamic-oxaloacetic transaminase 1 or aspartate (Asp) 
aminotransferase (GOT1) as part of the malate-Asp shuttle. Glu has three central metabolic 
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pathways in astrocytes. 1) Glu can be converted to Gln by GS and exported to neurons by the 
sodium-coupled neutral amino acid transporter 3 (SNAT3). 2) Glu is exchanged via xCT for 
extracellular cystine that is reduced to Cys. Extracellular Glu can be uptaken back by astrocytes 
by EAAT1/2. Finally, 3) Glu, Gly and Cys are precursors of GSH, which is also exported to 
neurons via MRP1. 2.5: The ER acts as a store for intracellular calcium, where the 
sarco/endoplasmic reticulum calcium ion ATPase (SERCA) pumps cytosolic Ca2+ into the ER. 
Ca2+ signaling is tightly regulated by the activation of IP3R that release Ca2+ from ER stores, as 
well as by the activation of plasma membrane Ca2+ channels. Mitochondria can buffer Ca2+ by 
its transport across the inner mitochondrial membrane to the matrix viaMCU), while the export is 
performed by mNCX and mHCX. Mitochondria can also transport Ca2+ in and out of the 
mitochondria via the activation of distinct Ca2+ permeable channels. In the matrix, Ca2+ 
stimulates TCA carbon flux by binding to PDH, IDH, and αKGDH, increasing the activity of the 
ETC and ATP production. 2.6: Cyt C is held close to the inner mitochondrial membrane by 
cardiolipin (not shown), acting as a component of ETC. Dissociation of Cyt C from cardiolipin, 
through oxidative or enzymatic means, coupled with permeabilization of the outer mitochondrial 
membrane by the formation of Bax/Bak oligomeric channels, allows Cyt C to escape into the 
cytosol. Cytosolic Cyt C associates with apoptotic protease-activating factor 1 (APAF1), forming 
the apoptosome and leading to the activation of caspases to initiate apoptosis. AGC, aspartate-
glutamate carrier; CPT1 or 2, carnitine palmitoyltransferase isoform 1 or 2; MDH1 or 2, malate 
dehydrogenase isoform 1 or 2; MPC1, mitochondrial pyruvate carrier 1; OGC, 2-oxoglutarate (α-
ketoglutarate) carrier. 
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